Jonathan A. Bernstein, MD - BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Treatment

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME information, and to apply for credit, please
visit us at PeerView.com/WQU865. CME credit will be available
until May 6, 2025.


BTK Inhibition Transforming the Landscape of Chronic Spontaneous
Urticaria Treatment


In support of improving patient care, PVI, PeerView Institute for
Medical Education, is jointly accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the
Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis activity is supported by an
educational grant from Novartis Pharmaceuticals Corporation.


Disclosure information is available at the beginning of the video
presentation.